TRPC3

Jiaxing Wang1, Sicheng Zhang1, Vijay K Boda1

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, United States.

PubMed
概括

研究人员开发了一种新型TRPC3抗剂,化合物60a,在与TRPC3蛋白功能障碍相关的疾病中显示出潜在治疗用途的强度和选择性得到改善.